Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
29-Dec-2021
INOVIQ Appendix 4G and Corporate Governance Statement
24-Dec-2021
Chinese Patent Issued in BARD1 Patent Family for Lung Cancer
22-Dec-2021
Appendix 3Y - Change of Director's Interest Notice x 4
13-Dec-2021
Notification regarding unquoted securities - IIQ
8-Dec-2021
BARD1 Changes its Name to INOVIQ
7-Dec-2021
Cleansing Notice - Issued of Four Shares - Resolution 5 AGM
7-Dec-2021
Application for quotation of securities - BD1
2-Dec-2021
Application for quotation of securities - BD1
30-Nov-2021
Results of 2021 Annual General Meeting
29-Nov-2021
AGM Presentation
1
2
3
4
5
6
7
8
9
Next
